| All LVNC phenotype patients and all healthy subjects | Subgroup A vs. B | Subgroup A vs. C | Subgroup A vs. D | Subgroup C vs. D |
---|---|---|---|---|---|
LVNC phenotype patients (normal LV volumetrics) and healthy subjects (normal LV volumetrics) | LVNC phenotype patients (normal LV volumetrics) and healthy subjects (normal LV volumetrics, not meeting any LVNC criteria) | LVNC phenotype patients (normal LV volumetrics) and healthy subjects (normal LV volumetrics, meeting one or more LVNC criteria) | Healthy subjects (normal LV volumetrics, not meeting any LVNC criteria) and healthy subjects (normal LV volumetrics, meeting one or more LVNC criteria) | ||
AUC | AUC | AUC | AUC | AUC | |
GRS | 0.85 (0.78, 0.92) | 0.78 (0.66, 0.90) | 0.84 (0.70, 0.97) | 0.72 (0.57, 0.88) | 0.65 (0.46, 0.84) |
GCS | 0.86 (0.79, 0.93) | 0.80 (0.69, 0.91) | 0.86 (0.74, 0.98) | 0.76 (0.61, 0.90) | 0.68 (0.49, 0.87) |
GLS | 0.83 (0.75, 0.91) | 0.69 (0.56, 0.83) | 0.75 (0.59, 0.90) | 0.65 (0.48, 0.82) | 0.65 (0.46, 0.84) |